14 Feb 2022
Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.
On Friday, surprising news emerged from China's pharmaceutical regulator (NMPA):
Pfizer's COVID-19 treatment drug – Paxlovid – has received conditional approval to register in China.It's the first oral pill specifically developed for the disease to be cleared by regulators.
Business wheels ar...
April 19, 2024
We just finished reading Beijing's new three-year plan to cultivate digital talents. The policy was jointly released on April 2 by a phalanx of regulators, including the human resource ministry (MoHRSS), the Ministry of Science and Technology (MoST), and the… Read More »
April 18, 2024
The Chinese and US militaries have agreed to continue disagreeing. On Tuesday, Defense Minister Dong Jun held a video call with US Defense Secretary Lloyd Austin. Why it matters: This is the first direct contact between the defense honchos since… Read More »
April 18, 2024
Retired officials are calling for the Party to radically rethink its approach to the private sector. On Saturday, a group of former and sitting officials and private businesspeople held a symposium in Beijing to discuss innovating Party theory regarding private… Read More »